Skip to main content
SpringerLink
Log in

Age-related macular degeneration

  • Review Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Age- related macular degeneration (AMD), a bilateral progressive macular disease, represents the major cause of blindness among elderly people living in Western countries. Clinical features of AMD vary from the initial asymptomatic aspects, drusen and retinal pigment epithelium alterations, to severe atrophic or exudative changes in the advanced stages, characterized by the irreversible decrease of visual function. Current epidemiologic, pathogenetic and clinical data are reviewed, and the importance of the exact identification of patients at risk of evolution toward the exudative form is addressed. The therapeutic approach to AMD is also analyzed and the role of laser photocoagulation is discussed. (Aging Clin. Exp. Res. 5: 165- 176, 1993)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Coscas G.: Dégénérescences maculaires acquisés liées a l’âge et néovaiss eaux sous-rétiniens. Masson, Paris, 1991.

    Google Scholar 

  2. Bressler N.M., Bressler S.B., Fine S.L.: Age-related macular degeneration. Survey Ophthalmol. 32: 375–413, 1988.

    Article  CAS  Google Scholar 

  3. Sorsby A.: Reports on public health and medical subjects. HMSO, London, 1966.

    Google Scholar 

  4. Leibowitz H.M., Krueger D.E., Mauder L.R., Milton R.C., Kini M.M., Kahn H.A., Nickerson R.J., Pool J., Colton T.L., Ganley J.P., Loewenstein J.I., Dawber T.R.: The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in a general population of 2631 adults, 1973–1975. Survey Ophthalmol. 24 (Suppl.): 335–610, 1980.

    Article  CAS  Google Scholar 

  5. Ferris F.L. III: Senile macular degeneration: review of epidemiologic features. Am. J. Epidemiol. 118: 132–151, 1983.

    PubMed  Google Scholar 

  6. Ferris F.L. III., Fine S.L., Hyman L.A.: Age-related macular degeneration and blindness due to neovascular maculopathy. Arch. Ophthalmol. 102: 1640–1642, 1984.

    Article  PubMed  Google Scholar 

  7. Ganley J., Roberts J.: Eye conditions and related need for medical care among persons 1-74 years of age, United States, 1971–1972. Vital and Health Statistics, Series 11, n.228, DHHS Publication n.(PHS) 83-1678. GPO, Washington, D.C., March 1993.

    Google Scholar 

  8. Vinding T.: Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. 67: 609–661, 1989.

    CAS  Google Scholar 

  9. Vinding T.: Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. 68: 162–167, 1990.

    CAS  Google Scholar 

  10. Vinding T.: Occurence of drusen, pigmentary changes and exudative changes in the macula with reference to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. 68: 410–414, 1990.

    CAS  Google Scholar 

  11. Martinez G.S., Campbell A., Reinken J., Allan B.C.: Prevalence of ocular disease in a population study of subjects 65 years old and older. Am. J. Ophthalmol. 94: 181–189, 1982.

    PubMed  CAS  Google Scholar 

  12. Yannuzzi L.A., Gitter K.A., Schatz H.: The macula. Williams and Wilkins Company, Baltimore, 1986.

    Google Scholar 

  13. Sarks S.H., Sarks J.P.: Age-related macular degeneration: atrophic form. In: Ryan S.J., Schachat A.P., Murphy R.P., Patz A. (Eds.), Retina. Medical retina. The CV Mosby Co., St.Louis, 1989, vol.2, pp.149–173.

    Google Scholar 

  14. Elman M.J., Fine S.L.: Exudative age-related macular degeneration. In: Ryan S.J., Schachat A.P., Murphy R.P., Patz A. (Eds.), Retina. Medical retina. The CV Morsby Co., St. Louis, 1989, vol. 2, pp.175–199.

    Google Scholar 

  15. Gass J.D.M.: Stereoscopic atlas of macular diseases: diagnosis and treatment, ed.3. The CV Morsby Co., St. Louis, 1987, pp.60–67.

    Google Scholar 

  16. Green W.R., Mc Donnell P.J., Yeo J.H.: Pathologic features of senile macular degeneration. Ophthalmology 92: 615–627, 1985.

    PubMed  CAS  Google Scholar 

  17. Fine A.M., Elman M.J., Ebert J.E., Prestia P.A., Starr J.S., Fine S.L.: Earliest symptoms caused by neovascular membranes in the macula. Arch. Ophthalmol. 104: 513–514, 1986.

    Article  PubMed  CAS  Google Scholar 

  18. Sarks S.H.: Drusen and their relationship to senile macular degeneration. Aust. J. Ophthalmol. 8: 117–130, 1980.

    Article  PubMed  CAS  Google Scholar 

  19. Sarks S.H., Penfold P.L., Killingsworth M.C., Van Diel D.: Patterns in macular degeneration. In: Ryan S.J., Dawson A.K., Little H.L. (Eds.), Retinal diseases. Grune and Stratton Inc., Orlando, Florida, U.S.A., 1985, pp. 87–93.

    Google Scholar 

  20. Klein B., Klein R.: Cataracts and macular degeneration in older Americans. Arch. Ophthalmol. 100: 571–573, 1982.

    Article  PubMed  CAS  Google Scholar 

  21. Gibson J.M., Rosenthal A.R., Laveny J.: A study of the prevalence of eye disease in the elderly in an English community. Trans. Ophthalmol. Soc. UK 104: 196–203, 1985.

    PubMed  Google Scholar 

  22. Hyman L.G., Lilienfeld A.M., Ferris F.L. III, Fine S.L.: Senile macular degeneration: a case-control study. Am. J. Epidemiol. 118: 213–227, 1983.

    PubMed  CAS  Google Scholar 

  23. Delaney W., Oates R.: Senile macular degeneration: a preliminary study. Ann. Ophthalmol. 14: 21–24, 1982.

    PubMed  Google Scholar 

  24. Maltzman B.A., Mulvihill M.M., Greenbaum A.: Senile macular degeneration and risk factors: a case-control study. Ann. Ophthalmol. 11: 1197–1201, 1979.

    PubMed  CAS  Google Scholar 

  25. Weiter J.J., Delori F.C., Wing G.L.: Relationship of senile macular degeneration to ocular pigmentation. Am. J. Ophthalmol. 99: 185–187, 1985.

    PubMed  CAS  Google Scholar 

  26. Sperduto R.D., Hiller R.: Systemic hypertension and age-related maculopathy in the Framingham Eye Study. Arch. Ophthalmol. 104: 216–219, 1986.

    Article  PubMed  CAS  Google Scholar 

  27. Blumenkranz M.S., Russel S.R., Robey M.G., Kott-Blumenkranz R., Penneys N.: Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthamology 96: 552–558, 1986.

    Google Scholar 

  28. West S.K., Rosenthal F.S., Bressler N.M., Bressler S.B., Munoz B., Fine S.L., Taylor H.R.: Exposure to sunlight and other risk factors for ARMD. Arch. Ophthalmol. 107: 875–879, 1989.

    Article  PubMed  CAS  Google Scholar 

  29. Silverstone B.Z., Landau L., Berson D., Sternbuch J.: Zinc and copper metabolism in patients with SMD. Ann. Ophthalmol. 17: 419–422, 1985.

    PubMed  CAS  Google Scholar 

  30. Newsome D.A., Swartz M., Leone N.C., Hewitt A.T., Wolford F., Miller E.D.: Macular degeneration and elevated serum ceruloplasmin. Invest. Ophthalmol. Vis. Sci. 27: 1675–1680, 1986.

    PubMed  CAS  Google Scholar 

  31. Newsome D.A., Swartz M., Leone N.C., Elston R.C., Millers D.: Oral zinc in macular degeneration. Arch. Ophthalmol. 106: 192–198, 1988.

    Article  PubMed  CAS  Google Scholar 

  32. Paetkan M.E., Boyd T.A.S., Grace M.: Senile disciform macular degeneration and smoking. Can. J. Ophthalmol. 13: 67–71, 1978.

    Google Scholar 

  33. Barondes M.J., Pauleikhoff D., Chisholm I.H., Minassian D., Bird A.C.: Bilaterality of drusen. Er. J. Ophthalmol. 74: 180–182, 1990.

    CAS  Google Scholar 

  34. Bressler N.M., Bressler S.B., Jacobson L.: Clinical characteristics of drusen in patients with exudative versus non exudative age-related macular degeneration. Retina 8: 109–114, 1988.

    Article  PubMed  CAS  Google Scholar 

  35. Sarks S.H.: Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust. J. Ophthalmol. 10: 91–97, 1982.

    Article  PubMed  CAS  Google Scholar 

  36. Sarks S.H., Penfold P., Killingsworth M.C., Moussa A.Y.: Drusen and their relationship to choroidal neovascularization. Acta XXIV Int. Congr. Ophthalmol., San Francisco, October 31-November 5, 1982, Henkind P. J.B. Lippincott, Philadelphia, 1: 401–404, 1983.

    Google Scholar 

  37. Smiddy W.E., Fine S.L.: Prognosis of patients with bilateral macular drusen. Ophthalmology91: 271–277, 1984.

    PubMed  CAS  Google Scholar 

  38. Pauleikhoff D., Barondes M.J., Minassian D., Chisholm I.H., Bird A.C.: Drusen as risk factors in age-related macular disease. Am. J. Ophthalmol. 109: 38–43, 1990.

    PubMed  CAS  Google Scholar 

  39. Bressler S.B., Maguire M.G., Bressler N.M., Fine S.L., the MPSG: Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch. Ophthalmol. 108: 1442–1447, 1990.

    Article  PubMed  CAS  Google Scholar 

  40. Eisner A., Stoumbos V.D., Klein M.L., Fleming S.A.: Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 32: 8–20, 1991.

    PubMed  CAS  Google Scholar 

  41. Young R.W.: Pathophysiology of age-related macular degeneration. Surv. Ophthalmol. 31: 291–306, 1987.

    Article  PubMed  CAS  Google Scholar 

  42. Glaser B.M., Campochiaro P.A., Davis J.L. Jr., Sato M.: Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch. Ophthalmol. 103: 1870–1875, 1985.

    Article  PubMed  CAS  Google Scholar 

  43. Glaser B.M., Davis J.L. Jr., Campochiaro P.A.: Human RPE can inhibit proteases involved in neovascularization. Invest. Ophthalmol. Vis. Sci. 27 (Suppl): 306, 1986.

    Google Scholar 

  44. Glaser B.M., Davis J., Hyer K., Jerdan J., Hewitt T., Krause W.: Purification of a diffusible RPE-derived protease inhibitor and localization within Bruch’s membrane: possible role in the control of intraocular neovascularization. Invest. Ophthalmol. Vis. Sci. 28 (Suppl.): 49, 1987.

    Google Scholar 

  45. Connor T., Glaser B.M.: RPE cells can simultaneously release inhibitors and stimulators of endothelial cell proliferation. Invest. Ophthalmol. Vis. Sci. 28 (Suppl.): 203, 1987.

    Google Scholar 

  46. Glaser B.M., Adamson I., Lansing M., Jerdan J., Davis J.: An urokinase inhibitor derived from human RPE cells inhibits neovascularization in vivo. Invest. Ophthalmol. Vis. Sci. 30 (Suppl.): 395, 1989.

    Google Scholar 

  47. Sarks S.H.: Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 60: 324–341, 1976.

    Article  PubMed  CAS  Google Scholar 

  48. Feeney-Burns L., Ellersieck M.: Age-related changes in the ultrastructure of Bruch’s membrane. Am. J. Ophthalmol. 100: 686–697, 1985.

    PubMed  CAS  Google Scholar 

  49. Burns R.P., Feeney-Burns L.: Clinico-morphologic correlations of drusen of Bruch’s membrane. Trans. Am. Ophthalmol. Soc. 78: 206–225, 1980.

    PubMed  CAS  Google Scholar 

  50. Ishibashi T., Sorgente N., Patterson R., Ryan S.J.: Pathogenesis of drusen in the primate. Invest. Ophthalmol. Vis. Sci. 27: 184–193, 1986.

    PubMed  CAS  Google Scholar 

  51. Pauleikhoff D., Harper C.A., Marshall J., Bird A.C.: Aging changes in Bruch’s membrane. A histochemical and morphologic study. Ophthalmology97: 171–178, 1990.

    PubMed  CAS  Google Scholar 

  52. Bird A.C.: Bruch’s membrane changes with age. Br. J. Ophthalmol. 76: 166–168, 1992.

    Article  PubMed  CAS  Google Scholar 

  53. Penfold P.L., Killingsworth M.C., Sarks S.H.: Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch. Klin. Exp. Ophthalmol. 223: 69–76, 1985.

    Article  CAS  Google Scholar 

  54. Penfold P.L., Killingsworth M.C., Sarks S.H.: Senile macular degeneration: the involvement of giant cells in atrophy of the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 27: 364–371, 1986.

    PubMed  CAS  Google Scholar 

  55. Penfold P.L., Provis J.M., Billson F.A.: Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch. Klin. Exp. Ophthalmol. 225: 70–76, 1987.

    Article  CAS  Google Scholar 

  56. Bressler N.M., Bressler S.B., West S.K., Fine S.L., Taylor H.R.: The grading and prevalence of macular degeneration in Chesapeake Bay Watermen. Arch. Ophthalmol. 107: 847–851, 1989.

    Article  PubMed  CAS  Google Scholar 

  57. Klein R., Davis M.D., Magli Y.L. Klein B.E.K.: Wisconsin Age-Related Maculopathy Grading System. Madison, Department of Ophthalmology, University of Wisconsin School of Medicine, 1991. US. Dept. of Commerce. Available from: National Technical Information Service, 5285 Port Royal Rd., Springfield, VA 22161. Accession PB91-184267/AS.

  58. Scheider A., Kaboth A., Neuhaser L.: Detection of subretinal neovascular membranes with Indocyanine Green and an Infrared Scanning Laser Ophthalmoscope. Am. J. Ophthalmol. 113: 45–51, 1992.

    PubMed  CAS  Google Scholar 

  59. Amsler M.: Earliest symptoms of disease of the macula. Br. J. Ophthalmol. 37: 521–537, 1953.

    Article  PubMed  CAS  Google Scholar 

  60. Wall M., Sadun A.: New; methods of sensory visual testing. Springer-Verlag, New York, 1989.

    Book  Google Scholar 

  61. Kleiner R.C., Enger C., Alexander M.F., Fine S.L.: Contrast sensitivity in age-related macular degeneration. Arch. Ophthalmol. 106: 55–57, 1988.

    Article  PubMed  CAS  Google Scholar 

  62. Sunness J.S., Johnson M.A., Massof R.W., Marcus S.: Retinal sensitivity over drusen and non drusen areas. A study using fundus perimetry. Arch. Ophthalmol. 106: 1081–1084, 1988.

    Article  PubMed  CAS  Google Scholar 

  63. Sunness J.S., Massof R.W., Johnson M.A., Bressler N.M., Bressler S.B., Fine S.L.: Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmology96: 375–381, 1989.

    PubMed  CAS  Google Scholar 

  64. Collins M., Brown B.: Glare recovery and age-related maculopathy. Clin. Vis. Sci. 4: 145–153, 1989.

    Google Scholar 

  65. Brown B., Kitchin J.L.: Dark adaptation and the acuity luminance response in senile macular degeneration (SMD). Am. J. Optom. Physiol. Optics60: 645–650, 1983.

    Article  CAS  Google Scholar 

  66. Eisner A., Fleming A., Klein M.L., Mauldin W.M.: Sensitivities in older eyes with good acuity: eyes whose fellow eye had exudative AMD. Invest. Ophthalmol. Vis. Sci. 28: 1832–1837, 1987.

    PubMed  CAS  Google Scholar 

  67. Brown B., Tobin C, Roche N., Wolanowski A.: Cone adaptation in age-related maculopathy. Am. J. Optom. Physiol. Optics63: 450–454, 1986.

    Article  CAS  Google Scholar 

  68. Young R.W.: Solar radiation and age-related macular degeneration. Surv. Ophthalmol. 32: 252–269, 1988.

    Article  PubMed  CAS  Google Scholar 

  69. Newsome D.A., Rothman R.J.: Zinc uptake in vitro by human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 28: 1795–1799, 1987.

    PubMed  CAS  Google Scholar 

  70. Newsome D.A., Swartz M., Leone N.C., Elston R.C., Miller E.: Oral zinc in macular degeneration. Arch. Ophthalmol. 106: 192–198, 1988.

    Article  PubMed  CAS  Google Scholar 

  71. Silverstone B., Seelenfreund M.H., Berson D.: Zinc and copper metabolism study in patients with high myopia and senile macular degeneration. Doc. Ophthalmol. Proc. Ser. 50: 215–218, 1987.

    Article  Google Scholar 

  72. Bressler N.M., Bressler S.B., Gragoudas E.S.: Clinical characteristics of choroidal neovascular membranes. Arch. Ophthalmol. 105: 209–213, 1987.

    Article  PubMed  CAS  Google Scholar 

  73. Macular Photocoagulation Study Group: Argon laser photocoagulation for neovascular maculopathy after five years. Results from randomized clinical trials. Arch. Ophthalmol. 109: 1109–1114, 1991.

    Article  Google Scholar 

  74. Macular Photocoagulation Study Group: Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch. Ophthalmol. 109: 1219–1231, 1991.

    Google Scholar 

  75. Macular Photocoagulation Study Group: Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch. Ophthalmol. 109: 1242–1257, 1991.

    Article  Google Scholar 

  76. Macular Photocoagulation Study Group: Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch. Ophthalmol. 104: 503–512, 1986.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Ophthalmology, University of Padova, Padova, Italy

    Tatiana Segato, E. Midena & M. C. Blarzino

Authors
  1. Tatiana Segato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Midena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. C. Blarzino
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Segato, T., Midena, E. & Blarzino, M.C. Age-related macular degeneration. Aging Clin Exp Res 5, 165–176 (1993). https://doi.org/10.1007/BF03324151

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324151

Keywords

Search

Navigation